Page last updated: 2024-10-27

gabapentin and Lacrimal Apparatus Diseases

gabapentin has been researched along with Lacrimal Apparatus Diseases in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Lacrimal Apparatus Diseases: Diseases of the LACRIMAL APPARATUS.

Research Excerpts

ExcerptRelevanceReference
"Gabapentin (Neurontin) was then started with improvement at 1800 mg per day."5.31SUNCT syndrome responsive to gabapentin (Neurontin). ( Graff-Radford, SB, 2000)
"Gabapentin (Neurontin) was then started with improvement at 1800 mg per day."1.31SUNCT syndrome responsive to gabapentin (Neurontin). ( Graff-Radford, SB, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Graff-Radford, SB1

Other Studies

1 other study available for gabapentin and Lacrimal Apparatus Diseases

ArticleYear
SUNCT syndrome responsive to gabapentin (Neurontin).
    Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:5

    Topics: Acetates; Amines; Analgesics; Conjunctival Diseases; Cyclohexanecarboxylic Acids; Gabapentin; gamma-

2000